Petra Pharma
is a developer of novel small molecule inhibitors for the treatment of cancer and metabolic diseases... Read morePetra Pharma
is a developer of novel small molecule inhibitors for the treatment of cancer and metabolic diseases... Read more
News
Apr 28, 2022
FirstWord Pharma
Petra Pharma: 180 Degree Capital Receives $12.3 Million, or $1.19 Per Share, in Cash From Buyout of Its Potential Future Milestones From the Acquisition of Petra Pharma Corporation by Lilly
Apr 02, 2019
FirstWordPHARMA
Petra Pharma: Petra Pharma Strengthens Management Team With Recent Leadership Appointments
Mar 20, 2019
Contract Pharma
Petra Pharma: Petra Pharma Licenses Takeda's Serabelisib
Dec 01, 2018
PR Newswire
Press Release: Petra Pharma : Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting
Apr 11, 2018
Business Wire
Press Release: Petra Pharma : Evotec Forms Collaboration with Petra Pharma on Indigo Platform
Sep 19, 2017
PharmiWeb
Petra Pharma: Petra Pharma and Schrödinger Announce Research Collaboration
Jul 27, 2017
BioSpace
Petra Pharma: Petra Pharma Appoints Executive And Scientific Leadership Teams
Jan 09, 2017
BioSpace
Petra Pharma: What You Need to Know About Petra Pharma
Jan 10, 2016
Xconomy
Petra Pharma: Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup
Jan 05, 2016
PE Hub Network
Petra Pharma: Petra Pharma racks up $48 mln Series A
Petra Pharma Competitors
1
2
3
4
5
6
7
8
9
10